India  

Covaxin

Vaccine against COVID-19

Covaxin    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Covaxin: Vaccine against COVID-19
Covaxin is an inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research.

1
shares
ShareTweetSavePostSend
 
Covaxin gets emergency use approval for children aged 2-18 years | Oneindia News [Video]

Covaxin gets emergency use approval for children aged 2-18 years | Oneindia News

In a big development today, the Subject Expert Committee on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group. Meanwhile, Congress leader..

Credit: Oneindia     Duration: 03:37Published
WHO expert panel to decide today on emergency use nod to Bharat Biotech’s Covaxin | Oneindia News [Video]

WHO expert panel to decide today on emergency use nod to Bharat Biotech’s Covaxin | Oneindia News

An expert panel of the WHO is going to take a decision on emergency use listing authorisation of Bharat Biotech’s Covaxin tentatively at 4:45 pm today. #Covaxin #WHO #EUL

Credit: Oneindia     Duration: 01:23Published

You Might Like


Delay in Covaxin's approval, WHO awaits crucial info

Until Covaxin gets an emergency use authorisation from WHO it cannot get widespread acceptability as a safe and effective vaccine around the world.
DNA - Published

Need more info, can’t cut corners on Covaxin: WHO

The WHO said on Monday it was “aware that many people are waiting for WHO’s recommendation for Covaxin to be included in the Covid-19 emergency use listing (EUL)” but that it “cannot cut..
IndiaTimes - Published

Cannot cut corners, need to thoroughly evaluate product before recommending emergency use: WHO on Covaxin

The WHO on Monday said it cannot cut corners and needs to thoroughly evaluate a product before recommending it for EUL to ensure it is safe and effective. “We are aware that many people are waiting..
IndiaTimes - Published

WHO's technical advisory group to meet on October 26 on EUL for Covaxin


IndiaTimes - Published

Covaxin's approval for children aged 2-18 years under experts' opinion, evaluation: Sources

The final approval for Bharat Biotech's Covaxin for children aged 2-18 years is under experts opinion and evaluation, stated Government sources on Thursday. Earlier on Tuesday, official sources had..
IndiaTimes - Published

India resumes vaccine exports as domestic stocks build up: Officials

One million shots of Covaxin produced by Bharat Biotech were shipped to Iran last week, the Indian embassy in Tehran said. Vaccines have also been sent to Nepal, a government source said, adding that..
IndiaTimes - Published

Expert panel recommends approving Covaxin for kids

The final approval of EUA from the drug regulator and inclusion of the vaccine in the national Covid immunisation programme for the paediatric population will take a few more days as data submitted by..
IndiaTimes - Published

Expert panel approves Covaxin for children between 2-18 years


IndiaTimes - Published

BIG BREAKING: DGCI approves Covaxin for kids in 2-18 age group

Covaxin approved for kids between 2-18
DNA - Published

SII gets nod to send Covid vaccines to Nepal, Bangaldesh, Myanmar, bulk to AstraZeneca; Bharat Biotech to Iran

The government has permitted Serum Institute of India (SII) to export 10 lakh Covishield doses each to Nepal, Myanmar and Bangladesh, while Bharat Biotech will provide Iran with 10 lakh doses of..
IndiaTimes - Published

Bharat Biotech submits clinical trial data of Covaxin in children to CDSCO


IndiaTimes - Published

WHO likely to decide on Covaxin emergency usage by next week

The approval for the emergency use authorization for Covaxin will most likely be issued by WHO in the next week, as per reports.
DNA - Published

WHO nod likely for Covaxin this month

The World Health Organisation’s approval for emergency use listing (EUL) of Bharat Biotech’s Covaxin is expected to take a few more weeks to arrive. The decision, however, will be taken in October..
IndiaTimes - Published

WHO to take final call on Covaxin EUL next week

The World Health Organisation (WHO) will be taking a final call on Bharat Biotech’s Emergency Use Listing (EUL) application for India’s first indigenously developed Covid-19 vaccine Covaxin next..
IndiaTimes - Published

WHO to give approval to Covaxin this month, say top health experts


IndiaTimes - Published

Centre got over 65.25 crore Covishield doses, 9.1 crore Covaxin jabs till September 19

The Centre has received over 65.25 crore Covishield doses from Serum Institute of India and 9.1 crore doses of Covaxin from Bharat Biotech till September 19, according to official documents. Serum..
IndiaTimes - Published

AIIMS Delhi Director hopes for early approval of Covid-19 vaccine Covaxin by WHO


IndiaTimes - Published

‘WHO stand on Covaxin a serious setback for India’


IndiaTimes - Published

Month after month, Covaxin missing production target

Homegrown Covaxin was to play a major role in vaccination against Covid-19. But eight months after the vaccination drive began, only one in 11 Indians has managed to get the first indigenous vaccine...
IndiaTimes - Published

Covaxin yet to receive WHO's emergency use clearance over technical queries: Report

The countries that have approved Covaxin include Iran, the Philippines, Mauritius, Mexico, Nepal, Guyana, Paraguay, and Zimbabwe.
DNA - Published

Covaxin supply to hit 5.5 cr doses from October: Bharat Biotech chairman

Covaxin output is all set to be ramped up to 5.5 crore doses in October from to 3.5 crore doses in September, Bharat Biotech’s chairman & managing director Dr Krishna Ella said on Tuesday. Pointing..
IndiaTimes - Published

Covaxin kids trial over, Bharat Biotech to submit data to DCGI next week


IndiaTimes - Published

Covaxin may soon get WHO approval as expert group scheduled to meet next month

SAGE members and Bharat Biotech officials will hold a meeting where safety and efficacy of Covaxin will be discussed on the basis trial data in India.
DNA - Published

Bharat Biotech awaits feedback from WHO for Covid-19 vaccine Covaxin's emergency use listing


IndiaTimes - Published

Covaxin may get WHO approval by month-end: NITI Aayog Member Dr VK Paul

India's indigenously-developed Covid vaccine Covaxin may soon receive Emergency Use Listing by the World Health Organisation, eventually enabling its recipients to travel abroad without mandatory..
DNA - Published

Centre says two doses of Covaxin must even for Covid-cured people

A person must take two doses of the anti-Covid vaccine, Covaxin, even after recovering from Covid-19, for being considered as a fully vaccinated individual, a Union health ministry official said on..
IndiaTimes - Published

Covishield, Covaxin & Sputnik V: You can now identify COVID-19 fake vaccines with these steps

India is currently administering 3 vaccines - Covidshield, Covaxin and Sputnik V. Here are some ways in which you can identify if the vaccine is fake
DNA - Published

First batch of Covaxin rolls out of Gujarat plant of Bharat Biotech


IndiaTimes - Published

First commercial batch of Covaxin rolls out from Bharat Biotech's Ankleshwar plant

In a move that will augment the supply of indigenously developed Covid-19 vaccine Covaxin, Bharat Biotech on Sunday announced the rollout of the first commercial batch of Covaxin from its Chiron..
IndiaTimes - Published

1 Covaxin dose to survivor equals 2 doses to uninfected

A single-dose of Bharat Biotech’s Covaxin in people who had been infected with Covid-19 previously generates antibody response similar to that provided by two doses of the vaccine in those without..
IndiaTimes - Published

ICMR study reveals how single Covaxin jab can be equivalent to two doses for special cases

A new study by ICMR has shown how a single Covaxin jab can be equivalent to two doses of the vaccine in previously COVID infected people.
DNA - Published

Covaxin single-dose to Covid infected equivalent to 2 doses for unaffected: ICMR

A single-dose of Covaxin provides a similar immunity response in previously Covid-infected people as those without previous history of Covid infection with two doses of vaccine, says Indian Council of..
IndiaTimes - Published

Majority Indians experienced no or mild side effects post 2 doses of Covishield and Covaxin: Report


IndiaTimes - Published

Covid vaccination for kids may start only by March ’22

Zydus Cadila's Covid-19 vaccine, ZyCoV-D, is expected to get an emergency use authorisation for the 12-18 cohort by end of August, whereas Bharat Biotech’s Covaxin – the world’s only vaccine..
IndiaTimes - Published

Kerala man files plea in court for Covishield after taking both doses of Covaxin, read why

The man Girikumar, 50 had filed a plea in the Kerala High Court stating that he works in Saudi Arabia which is yet to recognise the Covaxin.
DNA - Published

IIL starts Covaxin drug substance supply to Bharat Bio for 3-4 million doses per month


IndiaTimes - Published

75 million Covaxin doses supplied, more by September, says Bharat Biotech's Suchitra Ella


IndiaTimes - Published

Union health minister Mansukh Mandaviya meets WHO Chief Scientist Dr Soumya Swaminathan, discusses WHO's approval of Covaxin

Union health minister Mansukh Mandaviya on Thursday met World Health Organization (WHO) Chief Scientist Dr Soumya Swaminathan and held a discussion over the world body's approval of Bharat Biotech's..
IndiaTimes - Published

‘WHO call on emergency nod for Covaxin in September’


IndiaTimes - Published

WHO decision on Covaxin authorisation likely next month


IndiaTimes - Published

DCGI gives nod to conduct study on mixing Covaxin, Covishield

The Drugs Controller General of India (DCGI) has given approval to conduct a study on mixing Covaxin and Covishield vaccines. The research study will be done by Christian Medical College, Vellore, said..
IndiaTimes - Published

Permission granted to CMC Vellore to mix vaccine doses for research study: Dr V K Paul

DCGI has approved a proposal from the CMC Vellore to carry out trials on the mixed use of COVID-19 vaccines, Covishield and Covaxin in people.
DNA - Published

Govt approves Bharat Biotech's Ankleshwar plant for manufacturing Covaxin

Union health minister Mansukh Mandaviya on Tuesday said the government has approved Bharat Biotech’s vaccine manufacturing facility at Ankleshwar in Gujarat for manufacturing India’s first..
IndiaTimes - Published

Covishield-Covaxin mix offers better shield, says ICMR study

The study examined 18 individuals in UP who inadvertently received Covishield as the first jab and Covaxin as the second. "The findings suggest that immunisation with a combination of an adenovirus..
IndiaTimes - Published

Mixing and matching of Covaxin and Covishield vaccines show better result: ICMR


IndiaTimes - Published

136 crore Covishield, Covaxin doses to lead India's vaccination drive during August-December

More than 136 crore Covid-19 vaccine doses are expected to be available till the end of this year, informed the Centre. For the next four months, India's vaccine programme will be accelerated by the..
IndiaTimes - Published

Bharat Biotech issues clarification on quality concerns with Covaxin

The statement came after reports that test batches of Covaxin were not satisfactory and got rejected leading to delayed production.
DNA - Published

Covaxin receives certificate of Good Manufacturing Practice from Hungarian authorities


IndiaTimes - Published

Covaxin output set to rise; govt hopes to meet 135 crore-dose goal

Indian Immunologicals Limited is likely to start supply of an additional 2 million doses of Covaxin from August-September, whereas Bharat Biotech’s Ankleshwar facility is likely to add 6 million..
IndiaTimes - Published

Covaxin batches rejected due to stability issues caused disruption in July supply


IndiaTimes - Published


 Page 1  〉